Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(6 sites)

United States

University of California Irvine Health Chao Family Comprehensive Cancer Center, California City, California

University of Colorado Cancer Center, Colorado Springs, Colorado

Yale Cancer Center, New Haven, Connecticut

Barbara Ann Karmanos Cancer Institute, Michigan Center, Michigan

Gabrail Cancer Center, Ohio City, Ohio

Tranquil Clinical Research, Texas City, Texas